Senior insider sale
Co-Chief Executive Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$2.61M
190.69K shares
What this filing means
KLEE JUSTIN B. plans to sell 190.69K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $2.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001898314-26-000002
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
190.69K
Shares to sell
$2.61M
Approx. market value
57.53K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
N/A
3/2/2026
57.53KTotal acquired57.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units N/A | 57.53K | — |
| Total | 57.53K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
15.50K
Market value
$227.6K
2/2/2026
—Completed
Units to sell
2K
Market value
$27.7K
1/16/2026
—Completed
Units to sell
136.19K
Market value
$1.85M
1/15/2026
—Completed
Units to sell
7.71K
Market value
$85.6K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
29.28K
Market value
$423.8K
3/2/2026
Total
Units
190.69K
Value
$2.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 15.50K | $227.6K | — | Completed |
1/16/2026 | 2K | $27.7K | — | Completed |
1/15/2026 | 136.19K | $1.85M | — | Completed |
1/6/2026 | 7.71K | $85.6K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 29.28K | $423.8K | NASDAQ | Planned |
| Total | 190.69K | $2.61M | ||